Life Science Investing Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis and Systemic Lupus Erythematosus
Life Science Investing Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Life Science Investing Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
Life Science Investing Adicet Bio to Participate in a Fireside Chat at the 45th Annual Canaccord Genuity Growth Conference
Life Science Investing Adicet Bio Announces First Systemic Sclerosis Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
life science investing Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference
life science investing Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates
life science investing Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
life science investing Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy 28th Annual Meeting
life science investing Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference
life science investing Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress
Terra Clean's Fraser Lakes B Deposit Contains Significant Rare Earth Element Potential and is Listed as an Active Government of Canada Rare Earth Deposit
Silver47 Intersects High-Grade Mineralization in Step-Out Holes at Red Mountain, Alaska, and Hughes, Nevada
